Cargando…
Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study
BACKGROUND: Imatinib is the gold standard for the treatment of all phases of Philadelphia positive Chronic Myeloid Leukemia (CML). During treatment, patients may develop cytopenia. We aimed to study the baseline characteristics and factors associated with cytopenia at a Nairobi Hospital. METHODS: Th...
Autores principales: | McLigeyo, Angela, Rajab, Jamilla, Oyiro, Peter, Ezzi, Mohammed, Bett, Yatich, Ong’ondi, Matilda, Odhiambo, Andrew, Mwanzi, Sitna, Othieno-Abinya, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805406/ https://www.ncbi.nlm.nih.gov/pubmed/35105321 http://dx.doi.org/10.1186/s12885-021-09162-z |
Ejemplares similares
-
Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course
por: McLigeyo, Angela, et al.
Publicado: (2020) -
Prevalence and Predictors of Cisplatin-Induced Peripheral Neuropathy at the Kenyatta National Hospital
por: Ezzi, Mohammed S., et al.
Publicado: (2019) -
Plasma Cell Leukemia: A Review of 3 Cases Managed in Kenya
por: Ong'ondi, Matilda, et al.
Publicado: (2021) -
Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients
por: Gatua, Mercy, et al.
Publicado: (2022) -
COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study
por: Rea, Delphine, et al.
Publicado: (2020)